Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Purity | ≥98% |
|---|---|
| Formula | C18H18O4 |
| Formula Wt. | 298.33 |
| IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
| Appearance | White Crystal Powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
SIRT1/2 inhibitor.
Nucleoside (adenosine) analog; viral DNA polyme...
Amphibian tachykinin neuropeptide.
Peptide, c-Kit ligand fragment.
Iron chelator.
Sesquiterpene lactone found in Saussurea.
Impurity of diclofenac
D2 and D4 dopamine receptor inhibitor.
Synthetic compound related to sulforaphane.
Tenoxicam impurity
AurKB/C inhibitor.
Aromatase inhibitor.
DPP4 inhibitor.
Antimicrobial peptide, generated during fibrin ...
PDEδ inhibitor.
Acyclic nucleotide (adenosine) analog, adefovir...
Triterpene saponin found in species of Panax.
CDK9 inhibitor.
Endogenous cardiomodulatory peptide; NPR-A agon...
Tretinoin analog; RARα/β/γ agonist.